Vaxcyte, Inc. PCVX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -30.6%-5.0pp | -25.6%-4.8pp | -20.8%+0.8pp | -21.7%-2.0pp | -19.7%+0.7pp | |
| Return on invested capital | -37.6%-4.7pp | -32.9%-1.0pp | -31.9%+0.8pp | -32.7%-3.4pp | -29.3%+0.2pp | |
| Liquidity | ||||||
| Current ratio | 7.5×-0.4× | 7.9×-0.9× | 8.8×-2.3× | 11.1×-6.6× | 17.7×+4.9× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $21.48+8.8% | $19.73-7.1% | $21.24-5.9% | $22.58-4.3% | $23.58-13.0% | |
| Valuation | ||||||
| Market capitalization | $8.36B+38.5% | $6.04B+29.2% | $4.68B+6.3% | $4.4B-9.5% | $4.86B-52.3% | |
| Price / book | 2.8×+0.5× | 2.2×+0.6× | 1.6×+0.2× | 1.4×-0.1× | 1.5×-1.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Vaxcyte, Inc.'s ratios come from?
- Every ratio is computed from Vaxcyte, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.